Kinetics of the QuantiFERON®-TB Gold In-Tube test during treatment of patients with sputum smear-positive tuberculosis in relation to initial TST result and severity of disease

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 9, 2010, Pages 650-657

  Idh, Jonna ^a   Abate, Ebba ^a,b,c   Westman, Anna ^d   Elias, Daniel ^c   Janols, Helena ^e   Gelaw, Aschalew ^b   Getachew, Assefa ^b   Alemu, Shitaye ^b   Aseffa, Abraham ^c   Britton, Sven ^d   Stendahl, Olle ^a   Schn, Thomas ^a,f  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF GONDAR   (Ethiopia)

^c ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BLOOD DONOR; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; KINETICS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; SPUTUM SMEAR; TUBERCULIN TEST; TUBERCULOSIS; ADOLESCENT; BIOSYNTHESIS; CHI SQUARE DISTRIBUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; METHODOLOGY; MIDDLE AGED; PREDICTIVE VALUE; VIROLOGY;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; BLOOD DONORS; CD4 LYMPHOCYTE COUNT; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; KINETICS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 77956050239     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.482942     Document Type: Article

References (21)

1. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007;131:1898-1906
2. Pai M, Zwerling A, Menzies D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-184
3. Dheda K, Smit RZ, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009;15:188-200.
4. Soborg B, Andersen AB, Larsen HK, Weldingh K, Andersen P, Kofoed K, et al. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis 2007;39:554-559
5. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, Lardizabal AA, et al. Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 2008;46:474-5; author reply 475.
6. Raby E, Moyo M, Devendra A, Banda J, De Haas P, Ayles H, et al. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 2008;3:e2489.
7. Aabye MG, Ravn P, PrayGod G, Jeremiah K, Mugomela A, Jepsen M, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009;4:e4220.
8. Domínguez J, De Souza-Galvão M, Ruiz-Manzano J, Latorre I, Prat C, Lacoma A, et al. T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after anti-tuberculosis treatment. Diagn Microbiol Infect Dis 2009;63:43-51.
9. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. et al. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect 2009;58:197-204.
10. Kobashi Y, Sugiu T, Ohue Y, Mouri K, Obase Y, Miyashita N, et al. Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease. Intern Med 2008;47:1957-1961
11. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008;12:1146-1152
12. Adetifa IM, Lugos MD, Hammond A, Jeffries D, Donkor S, Adegbola RA, et al. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis 2007;7:122.
13. Wejse C, Gustafson P, Nielsen J, Gomes VF, Aaby P, Andersen PL, et al. TBscore: signs and symptoms from tuberculosis patientsin a low-resource setting have predictive value and may be used to assess clinical course. Scand J Infect Dis 2007;40:2111-2120
14. P erry S, Sanchez L, Yang S, Agarwal Z, Hurst P, Parsonnet J. Reproducibility of QuantiFERON-TB gold in-tube assay. Clin Vaccine Immunol 2008;15:425-432
15. Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, Kruger C, et al. Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol 2009;16:1170-1175
16. Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 2008;133: 1415-1420
17. Igari H, Watanabe A, Sato T. Booster phenomenon of QuantiFERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis 2007;11:788-791
18. Leyten EM, Prins C, Bossink AW, Thijsen S, Ottenhoff TH, van Dissel JT, et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis- specific interferon-gamma assay. Eur Respir J 2007;29:1212-1216
19. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174:349-355
20. Rangaka MX, Wilkinson KA, Seldon R, Van Cutsem G, Meintjes GA, Morroni C, et al. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med 2006;175:514-520
21. Van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, et al. Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med 2009;180:49-58.